Search Results for “EC” – Page 622 – media

Merck KGaA Plans Consumer Healthcare Sale After Strategic Review

Germany's Merck KGaA is looking to sell its $1 billion consumer healthcare unit after a group-wide strategic review.
- Source: thestreet
- 598
- September 7, 2017
Company Insight healthcare Market Views Merck
The World’s Largest and Most Powerful X-Ray Laser Just Went Online

The European XFEL is now online. Built to be the world's largest facility to house the most powerful x-ray lasers that can be produced, the XFEL would contribute to a better understanding of molecular and chemical process by imaging particles.
- Source: Futurism
- 539
- September 7, 2017
molecular x-ray XFEL
Ddu to Attend Expo Medical Expanding the South American Medical Trade Market

The 15th International Show for Products, Equipment and Services for the Healthcare Sector(Expo Medical) will be held at Centro Costa Salguero, Buenos Aires, Argentina from September 27 to September 29, 2017. As the leading global pharmaceutical and medical device B2B online platform, Ddu is going to attend the exhibition along with the products of high priority members and commits itself to the development of the South American medical trade market.
- Source: Ddu
- 816
- September 6, 2017
Exhibitions & Activities Expo Medical medical device pharmaceutical
UK researchers develop medical camera to see through body

Researchers from the University of Edinburgh and Heriot-Watt University in the UK have developed a medical camera that could see through the human body and track endoscopic tools used to evaluate internal conditions.
- Source: medicaldevice-network
- 452
- September 6, 2017
body endoscopic medical camera Researches
FDA approves Adherium’s new inhaler monitoring device

The US Food and Drug Administration (FDA) has cleared Adherium for its new inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler.
- Source: medicaldevices-business-review
- 572
- September 5, 2017
Company Insight FDA inhaler respiratory
Amgen Ventures Invests in GNS Healthcare to Advance Applications of its REFS™ Causal Machine Learning and Simulation AI Platforms

GNS Healthcare (GNS), a leading precision medicine company, today announced that it has raised an additional $6 million in equity from Amgen Ventures with participation from existing investor Alexandria Real Estate Equities. The funds will be used to further develop the company's REFS™ causal machine learning and simulation platform and solutions across drug discovery & development, value-based drug solutions, care management, and health system business optimization. With this investment, Amgen Ventures joins other leading biopharma companies Celgene and Zambon Pharmaceuticals, leading health plans Regence Blue Cross Blue Shield (Cambia Health Solutions), and Horizon Blue Cross of NJ and provider Heritage Provider Network, in addition to Mitsui, GHO Capital, and Fort Rock Capital as shareholders of GNS.
- Source: Prnewswire
- 565
- September 5, 2017
Market Views platform solution
Apollo Endosurgery gets CE-Mark for managed weight loss system

Apollo Endosurgery has received CE-Mark for its ORBERA365 Managed Weight Loss System allowing commercialisation in the European Union (EU) and member countries of the European Economic Area.
- Source: medicaldevice-network
- 871
- September 4, 2017
CE EU New Approvals weight loss
Hologic introduces new Brevera breast biopsy system

Medical technology firm Hologic has introduced new Brevera breast biopsy system with CorLumina imaging technology in the US.
- Source: diagnosticimaging.medicaldevices-business-review
- 499
- September 4, 2017
breast biopsy Company Insight
LabCorp completes $1.2B Chiltern buy

Diagnostics company LabCorp (NYSE:LH) said today that it has closed its $1.2 billion acquisition of contract research organization Chiltern International.
- Source: drugdeliverybusiness
- 661
- September 4, 2017
acquisition Clinical Market Views oncology
2nd International Conference on Pediatric Neurology

Pediatric Neurology 2017 will focus on the latest and exodus innovations in all areas of Pediatric neurology research which offers exclusive opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year's annual congress highlights the theme, "Channelizing the novel ideas for treating Pediatric Neurological Disorders" which reflects the innovative progress in Pediatric Neurology research.
- Source: drugs
- 590
- September 1, 2017
Exhibitions & Activities Pediatric Neurology

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.